Dr. Jackalina Van Kampen
Adjunct Professor, University of Prince Edward Island
Dr. Jackalina M. Van Kampen is currently Director of Preclinical Research at Neurodyn Life Sciences as well as Adjunct Professor in the Department of Biomedical Science at the University of Prince Edward Island. Prior to this, she was at the Mayo Clinic College of Medicine where she held the position of Assistant Professor of Molecular Neuroscience. She has a Bachelor of Science degree in Psychology from McGill University, a Master of Science degree in Neuroscience from the University of Western Ontario, and a Ph.D. in Neuroscience from the University of British Columbia, awarded in 2000.
Parkinson’s disease has been the main thrust of her career, beginning with graduate training under the supervision of Dr. A. Jon Stoessl, Director of the Pacific Parkinson’s Research Centre, and continuing through postdoctoral training with Dr. Harold Robertson, Research Director and co-founder of the Brain Repair Centre. In 2003, she joined the Mayo Clinic where she continued her study of Parkinson’s disease but also expanded her skillset to include studies of Alzheimer’s disease and other dementias. In 2008, she returned home to Canada to join the burgeoning biotechnology industry in Prince Edward Island. She has established a research program focused primarily on neuroprotection and neuronal recovery in models of neurodegenerative disease and currently holds a CIHR grant, studying the neurorestorative potential of adult neurogenesis in a rodent model of Alzheimer’s disease.
Dr. Van Kampen has also been working with Neurodyn to develop novel neuroprotective therapies for various neurological conditions, including Parkinson’s disease, Alzheimer’s disease, and ALS. This includes a promising progranulin-based gene therapy, which was supported, in part, through funding from the Michael J. Fox Foundation. She has also been involved in the development of a novel drug therapy for dementia, which has completed Phase 1b clinical trials. Under her adjunct status, Dr. Van Kampen also works with UPEI, executing research projects, teaching classes and supervising students. She is a member of the Society for Neuroscience, the Brain Repair Centre and the PEI Bioalliance. She has successfully served as chair of the organizing committee for NeuroConX, an annual meeting bringing together academia and industry in the field of neurodegenerative disease. This meeting has grown substantially over the last 6 years. Dr. Van Kampen is also a member of the Board of the Alzheimer’s Society of PEI and serves as reviewer for the Alzheimer’s Society of Canada.